Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04276155 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Study acronym: SCA FA
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 1, 2024 to Jun 22, 2027
    • Start date: Feb 22, 2021 to Aug 3, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 8 of 8 sites
    v6
  2. 2 versions Re-verified since Aug 2, 2022, no change to tracked fieldsv4-v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2020 to Feb 22, 2021
    • Study sites: 0 to 8
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with Acute Coronary Syndrome associated with de novo atrial fibrillation are randomized to benefit from either a conventional therapy associating dual antiplatelet therapy (DAPT) and anticoagulant or DAPT and an implantable monitoring device with a follow-up by telecardiology
Trial Details
NCT Number NCT04276155
Lead Sponsor Centre Hospitalier de PAU
Conditions
(from sponsor)		 Atrial Fibrillation, Myocardial Infarction
Related terms Acute Coronary Syndrome, Atrial Fibrillation, Myocardial Infarction
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov